The coronavirus will affect the medical supply chain coming from China. Various reports indicate that while 50% of Chinese factories are now open, only about half of these are actually producing medical products. Many Chinese employees are still working from home. While... Read More
As China pushes ahead with its policy of extracting price cuts from pharmaceutical manufacturers in exchange for access to its vast market, it is increasingly putting pressure on the profit margins of foreign and domestic drug manufacturers. Some drug firms are finding... Read More
For the first time, China on January 1 began regulating the use of customized medical devices, which are similar to already-approved devices, but custom-made to the specifications of a single patient based on prescribed needs. Until now, customized medical devices, often made... Read More
With the COVID-19 virus shaking global markets and economies, anti-viral drug developers around the world are increasing efforts to develop treatments for the disease. Western pharmaceutical firms and research organizations have launched accelerated research and testing programs for novel coronavirus vaccines. Among... Read More
This article was originally published on Medtech Intelligence. Artificial intelligence devices or products, known popularly as AI, imitate intelligent behavior or mimic human learning and reasoning. In its more basic forms, artificial intelligence has been used in the healthcare field to perform... Read More
As part of the first phase of a broader trade pact signed by Chinese and U.S. officials in January, China has agreed to enact a system to prevent infringement of drug patents, a move that may boost protections for branded drugs in... Read More
Fueled by a lack of access to preventative eye care and a dearth of public vision screening programs, myopia, and other ophthalmologic conditions are on the rise in East Asia. In one city in China, a 15-year study completed in 2015 found... Read More
Employing a raft of restrictive trade, financial, procurement, and insurance policies, Chinese authorities are increasingly insulating the country’s domestic medical device industry from foreign competition. Beginning in 2018, China began to require that a growing number of state-run hospitals buy domestically produced... Read More
To view these presentation slides, please click on DMF Registration in China. Read More
As China’s drug market grows exponentially, more foreign API, excipient and drug packaging material companies look to sell their products in China. In August 2016, to simplify the drug review procedure, the former CFDA announced that the review and approval of APIs,... Read More